Google has suspended business activity involving the transfer of hardware, software and key technical services with Huawei. Analysts say that could be a big blow to the...Technologyread more
Huawei Technologies will immediately lose access to updates to the Android operating system, a source close the matter told Reuters.Technologyread more
Huawei claims it has developed its own operating system for smartphones and laptops for "extenuating circumstances."Technologyread more
Current geopolitical tensions are making it harder and harder for oil-producing nations to make decisions that will help stabilize crude prices, Russian Energy Minister...Oilread more
Oil prices jumped on Monday after Saudi Energy Minister Khalid al-Falih indicated there was a consensus among OPEC and allied oil producers to continue limiting supply.Energyread more
Bank, property and healthcare stocks jumped, pushing Australian markets to a 11-year high, as Scott Morrison and the Liberal-led conservation government are poised for a...World Marketsread more
Trump's threat, posted on Twitter, comes amid rising international tensions in the Middle East as the U.S. has dispatched a carrier strike group and bomber task force to the...Politicsread more
Prime Minister Narendra Modi and his Bharatiya Janata Party are set to form the new government again, exit polls from India's month-long parliamentary elections show. But past...Electionsread more
The latest crisis in the uneasy French-German relationship was accelerated by Trump's decision to stop Germany's comfortable and decades-old free-riding on trade and security...Europe Politicsread more
While some fans of the long-running "Game of Thrones" felt satisfied by the show's final bow, others were quick to express their displeasure with how events unfolded.Entertainmentread more
Stocks in Asia were mixed on Monday amid a series of geopolitical developments across the region.Asia Marketsread more
The World Health Organization has published its first list of antibiotic resistant "priority pathogens" that pose the biggest threats to humans.
The agency created the list to spur research and development for new antibiotics that can counter bacteria that are increasingly resistant to treatment.
The bacteria that pose the greatest threat, those considered "critical" priority, are strains of bacteria resistant to multiple antibiotics that pose threats to patients in hospitals, nursing homes, or under certain kinds of treatment.
One bacteria not included in the WHO list is the one that causes tuberculosis because there is "already consensus that tuberculosis is the most important priority for R&D for new antibiotics," WHO's Marie-Paule Kieny said at a press conference Monday.
The list was compiled by the WHO and researchers from the Division of Infectious Diseases at the University of Tuebingen, Germany. The team used a list of criteria to evaluate each strain, considering things such as how deadly the infections from a bacterial strain can be, how frequently they show resistance to treatment, whether infections cause long stays in hospitals, and how easily they spread among animals and people.
"This list is a new tool to ensure R&D responds to urgent public health needs," said Kieny, WHO's assistant director-general for health systems and Innovation. "Antibiotic resistance is growing, and we are fast running out of treatment options. If we leave it to market forces alone, the new antibiotics we most urgently need are not going to be developed in time."
The list is a new step for the WHO, but it is not the first time a public health agency has listed high-risk bacterial strains. The U.S. Centers for Disease Control and Prevention also published a lengthy report on antibiotic resistance in 2013, including a similar list of exceptionally concerning strains of antibiotic resistant bacteria.
In that report, the CDC cited research suggesting antibiotic resistance costs $20 billion in excess direct health-care costs per year (in 2008 dollars), and an additional $35 billion a year in lost productivity.
WHO priority pathogens list for R&D of new antibiotics
Priority 1: Critical
Priority 2: High
Priority 3: Medium